NCT06868433 2026-03-04TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell CancerEmory UniversityPhase 1 Recruiting40 enrolled
NCT07441681 2026-03-02Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive CisplatinNRG OncologyPhase 3 Not yet recruiting454 enrolled
NCT05075980 2026-02-13Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT StudyMayo ClinicPhase 2 Recruiting174 enrolled
NCT06636734 2026-02-11Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP TrialEmory UniversityPhase 2 Recruiting28 enrolled
NCT06532279 2026-02-02Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck CancerNRG OncologyPhase 2 Recruiting98 enrolled
NCT00965003 2017-10-05MRI Laryngeal Imaging With a Surface CoilStanford UniversityPhase EARLY_PHASE1 Terminated3 enrolled